Our Mission

NASCSA's mission is to support, equip, and advocate for state controlled substances authorities, prescription monitoring program administrators, and other members in their work to advance the public's health, safety and welfare.

Visit NASCSA forum/newsgroup

Important News & Announcements

Surescripts Issues Advisory to pharmacies, pharmacy computer vendors, and electronic health records companies connected to their e-prescribing network

Posted 2/18/2024

February 14, 2024 - Surescripts last week issued the following Advisory to pharmacies, pharmacy computer vendors and electronic health records companies connected to their e-prescribing network.

Description: As of August 28, 2023, the electronic transfer...
Read More

DEA Extends Comment Period on Disposal

Posted 2/16/2024

The Regulatory Drafting and Policy Support Section of the US Drug Enforcement Administration is looking for additional comments on the disposal APRN published on 10-31-2023 at Read More

Administration Announces Update on Overdose Prevent Strategy

Posted 2/4/2024

On Feb. 1, the Substance Abuse and Mental Health Services Administration (SAMHSA) issued a final rule that updates regulations for Opioid Treatment Programs (OTP) and the standards for treatment of opioid use disorder (OUD). The rule makes some COVID-19-related flexibilities permanent, including...
Read More

DEA’s Diversion Control Division Launches Redesigned Website

Posted 1/16/2024

On Jan. 16, 2024, DEA launched a redesigned website to better educate the community of more than 1.2 million registrants on DEA?s role in to keeping communities safe through prevention of the diversion of controlled substances.

Check out the redesigned website: Read More

Missouri Implements Statewide Prescription Drug Monitoring Program

Posted 12/15/2023

December 13, 2023

JEFFERSON CITY, Mo. ? The State of Missouri?s statewide prescription drug monitoring program (PDMP) was activated on Wednesday, December 13, 2023. The purpose of PDMP is to reduce abuse and misuse of controlled substances such as opioids by making...
Read More

All news & announcements

Sponsor Spotlight

COMPASS Pathways

COMPASS Pathways is delighted to be a sponsor of NASCSA and looks forward to both engaging with controlled substances authorities, NASCSA leadership, and members to learn about their important work, and educate about our company's mission and the innovations underway using novel therapies.

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments.

We are developing innovative therapies and, when appropriate, combining them with psychological support and next-generation digital tools to forge new, sustainable mental health care pathways.

Our investigational COMP360 psilocybin therapy is currently undergoing phase 3 investigation in treatment-resistant depression. We are also assessing COMP360 in anorexia nervosa and post-traumatic stress disorder, across multiple clinical studies.

Learn more https://www.compasspathways.com

All Sponsors

State Controlled Substance and PMP Database

Click on a state to access the controlled substance and PMP database. Available information includes PMP and controlled substance contact information as well as PMP profiles. The database contains the most current information that is available to us. For the District of Columbia, Guam, and Puerto Rico, please use the button on the left for the inclusive drop down list.

Please use this form to contact NASCSA

* Please do not submit patient health information (PHI).